Smith & Nephew (SNN) Acquires Kalypto Medical; Adds to NPWT Pipeline
Tweet
Share
E-mailGet Alerts SNN Hot Sheet
Join SI Premium – FREE
Smith & Nephew (NYSE: SNN), announces the closing of the acquisition of privately-held Kalypto Medical, Inc., by its group company Smith & Nephew, Inc., adding to Smith & Nephew's own Negative Pressure Wound Therapy (NPWT) innovation pipeline and intellectual property portfolio.
Kalypto Medical is the manufacturer of the NPD 1000, a portable, ambulatory Negative Pressure Wound Therapy (NPWT) system. Kalypto has invested in NPWT innovation since 2006.
Smith & Nephew is not disclosing terms of this transaction.
Kalypto Medical is the manufacturer of the NPD 1000, a portable, ambulatory Negative Pressure Wound Therapy (NPWT) system. Kalypto has invested in NPWT innovation since 2006.
Smith & Nephew is not disclosing terms of this transaction.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Real and RE/MAX Holdings receive court approval for merger
- Solowin Holdings marks 10 years, expands into stablecoins and AI
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
